Brewer's yeast improves glycemic indices in type 2 diabetes mellitus

International Journal of Preventive Medicine

Volumn 4, Issue 10, 2013, Pages 1131-1138

  Hosseinzadeh, Payam ^a   Javanbakht, Mohammad Hassan ^a   Mostafavi, Seyed Ali ^a   Djalali, Mahmoud ^a   Derakhshanian, Hoda ^a   Hajianfar, Hossein ^b   Bahonar, Ahmad ^c   Djazayery, Abolghassem ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brewer's yeast; HbA1c; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; PLACEBO;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SACCHAROMYCES CEREVISIAE; TREATMENT DURATION;

EID: 84885465779     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Díaz-Apodaca BA, Ebrahim S, McCormack V, de Cosío FG, Ruiz-Holguín R. Prevalence of type 2 diabetes and impaired fasting glucose: Cross-sectional study of multiethnic adult population at the United States-Mexico border. Rev Panam Salud Publica 2010;28:174-81.
2. Schemmel KE, Padiyara RS, D'Souza JJ. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: A review. J Diabetes Complications 2010;24:354-60.
3. Ceriello A, Colagiuri S. International diabetes federation guideline for management of postmeal glucose: A review of recommendations. Diabet Med 2008;25:1151-6.
4. Mawatari S, Saito K, Murakami K, Fujino T. Absence of correlation between glycated hemoglobin and lipid composition of erythrocyte membrane in type 2 diabetic patients. Metabolism 2004;53:123-7.
5. Swapan KB. Genetic epidemiology of adult onset type 2 diabetes in Asian-Indian population: Past, present and future. Int J Hum Jenet 2006;6:1-13.
6. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: Methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health 2009;9:167.
7. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J 2008;49:571-6.
8. Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA.The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med J 2000;21:831-7.
9. Wang ZQ, Cefalu WT. Current concepts about chromium supplementation in type 2 diabetes and insulin resistance. Curr Diab Rep 2010;10:145-51.
10. Offenbacher EG, Pi-Sunyer FX. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 1980;29:919-25.
11. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National survey of risk factors for non-communicable diseases of Iran. Diabetes Care 2008;31:96-8.
12. Davis TM, Brown SG, Jacobs IG, Bulsara M, Bruce DG, Davis WA. Determinants of severe hypoglycemia complicating type 2 diabetes: The Fremantle diabetes study. J Clin Endocrinol Metab 2010;95:2240-7.
13. Wang MM. Serum cholesterol of adults supplemented with brewer's yeast or chromium chloride. Nutr Res 1989;9:989-98.
14. Racek J, Trefil L, Rajdl D, Mudrová V, Hunter D, Senft V. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol Trace Elem Res 2006;109:215-30.
15. Lai MH, Chen YY, Cheng HH. Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res 2006;76:391-7.
16. Li YC. Effects of brewer's yeast on glucose tolerance and serum lipids in Chinese adults. Biol Trace Elem Res 1994;41:341-7.
17. Grant AP, McMullen JK. The effect of brewers yeast containing glucose tolerance factor on the response to treatment in type 2 diabetics. A short controlled study. Ulster Med J 1982;51:110-4.
18. Nahas R, Moher M. Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician 2009;55:591-6.
19. Moyad MA. Brewer's/baker's yeast (Saccharomyces cerevisiae) and preventive medicine: Part II. Urol Nurs 2008;28:73-5.
20. Vinson JA, Bose P. The effect of high chromium yeast on the blood glucose control and blood lipids of normal and diabetic human subject. Nutr Rep Inter 1984;30:211-17.
21. Ravanshad SH, Khosraviboroujeni H, Sovayed M. The effect of brewer's yeast on blood sugar and lipid profile in dislipdemic type 2 diabetes. Mazandaran Med Sci Uni J 2005;35:42-7.
22. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-95.
23. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
24. Rabinowitz MB, Gonick HC, Levin SR, Davidson MB. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care 1983;6:319-27.
25. Wang ZQ, Qin J, Martin J, Zhang XH, Sereda O, Anderson RA, et al. Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. Metabolism 2007;56:1652-5.
26. Cefalu WT, Rood J, Pinsonat P, Qin J, Sereda O, Levitan L, et al. Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. Metabolism 2010;59:755-62.
27. Kleefstra N, Houweling ST, Bilo HJ. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care 2007;30:2154-63.
28. Cefalu WT, Rood J, Pinsonat P, Qin J, Sereda O, Levitan L, et al. Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus. Metabolism 2010;59:755-62.
29. Althuis MD, Jordan NE, Ludington EA, Wittes JT. Glucose and insulin responses to dietary chromium supplements: A meta-analysis. Am J Clin Nutr 2002;76:148-55.
30. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997;46:1786-91.